Novel Bruton's Tyrosine Kinase Inhibitor Bgb-3111 Demonstrates Potent Activity in Mantle Cell Lymphoma

被引：3
|
作者：
Li, Carrie J.
Liu, Yang
Bell, Taylor
Wang, Jack
Guo, Hui
Ahmed, Makhdum
Zhang, Hui
Lam, Laura T.
Nomie, Krystle
Wang, Lai
Zhang, Liang
Wang, Michael
机构：
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.5374.5374
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5374
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Metabolic Detection of Bruton's Tyrosine Kinase Inhibition in Mantle Cell Lymphoma Cells
    Lee, Seung-Cheol
    Shestov, Alexander A.
    Guo, Lili
    Zhang, Qian
    Roman, Jeffrey C.
    Liu, Xiaobin
    Wang, Hong Y.
    Pickup, Stephen
    Nath, Kavindra
    Lu, Pin
    Hofbauer, Samuel
    Mesaros, Clementina
    Wang, Y. Lynn
    Nelson, David S.
    Schuster, Stephen J.
    Blair, Ian A.
    Glickson, Jerry D.
    Wasik, Mariusz A.
    MOLECULAR CANCER RESEARCH, 2019, 17 (06) : 1365 - 1377
  • [22] Treatment of Patients with Relapsed or Refractory Mantle-Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase
    Song, Yuqin
    Zhou, Keshu
    Zou, Dehui
    Zhou, Jianfeng
    Hu, Jianda
    Yang, Haiyan
    Zhang, Huilai
    Ji, Jie
    Xu, Wei
    Jin, Jie
    Lv, Fangfang
    Feng, Ru
    Gao, Sujun
    Guo, Haiyi
    Zhou, Lei
    Elstrom, Rebecca
    Huang, Jane
    Novotny, William
    Wei, Rachel
    Zhu, Jun
    CLINICAL CANCER RESEARCH, 2020, 26 (16) : 4216 - 4224
  • [23] TAS5315, a Novel Bruton's Tyrosine Kinase (BTK) Inhibitor, Demonstrates Potent Efficacy in an Animal Model of Rheumatoid Arthritis
    Hosoi, Fumihito
    Yoshiga, Youhei
    Iguchi, Satoru
    Kaneko, Ryuusuke
    Nakachi, Yoshinori
    Akasaka, Daichi
    Yonekura, Kazuhiko
    Utsugi, Teruhiro
    Sasaki, Eiji
    Iwasawa, Yoshikazu
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [24] Durable remission with Bruton's tyrosine kinase inhibitor therapy in a patient with leptomeningeal disease secondary to relapsed mantle cell lymphoma
    Yohannan, Binoy
    Sridhar, Arthi
    Nguyen, Nghia
    Rios, Adan
    BMJ CASE REPORTS, 2022, 15 (06)
  • [25] Novel leflunomide analog inhibitor of Bruton's tyrosine kinase
    Mahajan, S
    Ghosh, S
    Sudbeck, E
    Zheng, YG
    Downs, S
    Uckun, FM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U283 - U283
  • [26] THE COMBINATION OF A NOVEL BRUTON TYROSINE KINASE (BTK) INHIBITOR PLS123 AND mTOR INHIBITOR EVEROLIMUS SYNERGISTICALLY INDUCES ANTI-TUMOUR ACTIVITY IN MANTLE CELL LYMPHOMA
    Li, J.
    Ding, N.
    Feng, L. X.
    Liu, Y. L.
    Song, W. W.
    Song, Yuyin Q.
    Zhu, J.
    ANTICANCER RESEARCH, 2015, 35 (07) : 4297 - 4298
  • [27] NOVEL MUTATION IN BRUTON'S TYROSINE KINASE IN PATIENT WITH CUTANEOUS T CELL LYMPHOMA
    Humpel, O.
    Kalkat, A.
    Hostoffer, R.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S139 - S139
  • [28] Evaluation of second-generation Bruton's tyrosine kinase inhibitors for the treatment of mantle cell lymphoma
    Lu, Jessie
    Do, Bryan
    Primeaux, Brian
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2025, 31 (02) : 230 - 235
  • [29] Safety and Activity of the Highly Specific BTK Inhibitor BGB-3111 in Combination with the PD-1 Inhibitor BGB-A317 in Patients with B-Cell Lymphoid Malignancies
    Cull, Gavin
    Opat, Stephen
    Trotman, Judith
    Hilger, James
    Zhang, Xiaoping
    Feng, Shibao
    Ro, Sunhee
    Huang, Jane
    Tam, Constantine S.
    BLOOD, 2017, 130
  • [30] A novel Bruton's tyrosine kinase inhibitor JDB175 shows potent efficacy to suppress central nervous system lymphoma
    Xia, Yong
    Li, Xue
    Jiang, Ning
    Wei, Xiawei
    MEDCOMM, 2023, 4 (06):
12345